7 Most pharmaceutical companies believe their Medical Legal Regulatory review process protects them from risk. In … Are Smart Compliance Systems Replacing Bottlenecks and Redefining Commercial Speed?Read more
Author: Krishna Aggarwal
Krishna Aggarwal is a business and technology enthusiast with a growing interest in the pharmaceutical, life sciences, and healthcare industry. He writes about pharmaceutical marketing, healthcare business strategy, digital transformation, and the role of data, AI, and analytics in modern pharma marketing and commercial decision-making. His interests lie at the intersection of finance, technology, and healthcare, particularly in how data-driven strategies are shaping the future of pharmaceutical sales, marketing, and market access.
The Silent Architects: How Private Equity Is Rewriting the Rules of Pharmaceutical Commercialization
The Silent Architects: How Private Equity Rewrote the Rules of Pharmaceutical Commercialization Private equity now controls … The Silent Architects: How Private Equity Is Rewriting the Rules of Pharmaceutical CommercializationRead more
Location Is the New Targeting: How Geofencing Is Changing Who Gets Diagnosed and Treated
Pharmaceutical marketing has always tried to reach the right doctor and the right patient at the … Location Is the New Targeting: How Geofencing Is Changing Who Gets Diagnosed and TreatedRead more
When a Drug Loses Its Patent, Marketing Becomes Defense, Not Growth
Pharmaceutical companies do not lose billions when a patent expires. They lose billions in the years … When a Drug Loses Its Patent, Marketing Becomes Defense, Not GrowthRead more
The Hidden Compliance Risk of AI in Pharmaceutical Promotion
Pharmaceutical companies are adopting generative AI faster than regulators can write guidance. That gap is where … The Hidden Compliance Risk of AI in Pharmaceutical PromotionRead more
The Truth About Drug Price Transparency Laws and Pharmaceutical Marketing Strategy
Drug price transparency laws are not just policy changes. They are forcing pharmaceutical companies to change … The Truth About Drug Price Transparency Laws and Pharmaceutical Marketing StrategyRead more
FDA Draft Guidance on AI in Pharmaceutical Advertising: What Pharma Marketers Must Know Now
The pharmaceutical industry spent decades building tightly controlled promotional systems where every word in an advertisement … FDA Draft Guidance on AI in Pharmaceutical Advertising: What Pharma Marketers Must Know NowRead more
The Uncomfortable Truth About Pharmaceutical Marketing Failure
Most pharmaceutical marketing teams believe their job is to convince doctors to prescribe their drug. That … The Uncomfortable Truth About Pharmaceutical Marketing FailureRead more
The Truth About Pharmaceutical Marketing in the United States
In most industries, marketing influences preference. In the United States pharmaceutical industry, marketing influences diagnosis, treatment … The Truth About Pharmaceutical Marketing in the United StatesRead more
AI-Driven Adverse Event Detection From Social Media: The New Frontline of Pharmacovigilance
When Side Effects Trend Before Regulators React In 2023, a mid-sized pharmaceutical company detected a potential … AI-Driven Adverse Event Detection From Social Media: The New Frontline of PharmacovigilanceRead more